209 related articles for article (PubMed ID: 33141904)
1. Breast Cancer Detection and Treatment Monitoring Using a Noninvasive Prenatal Testing Platform: Utility in Pregnant and Nonpregnant Populations.
Lenaerts L; Che H; Brison N; Neofytou M; Jatsenko T; Lefrère H; Maggen C; Villela D; Verheecke M; Dehaspe L; Croitor A; Hatse S; Wildiers H; Neven P; Vandecaveye V; Floris G; Vermeesch JR; Amant F
Clin Chem; 2020 Nov; 66(11):1414-1423. PubMed ID: 33141904
[TBL] [Abstract][Full Text] [Related]
2. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
3. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.
Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L
BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279
[TBL] [Abstract][Full Text] [Related]
4. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies.
Lenaerts L; Brison N; Maggen C; Vancoillie L; Che H; Vandenberghe P; Dierickx D; Michaux L; Dewaele B; Neven P; Floris G; Tousseyn T; Lannoo L; Jatsenko T; Bempt IV; Van Calsteren K; Vandecaveye V; Dehaspe L; Devriendt K; Legius E; Bogaert KVD; Vermeesch JR; Amant F
EClinicalMedicine; 2021 May; 35():100856. PubMed ID: 34036251
[TBL] [Abstract][Full Text] [Related]
7. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
8. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
[TBL] [Abstract][Full Text] [Related]
9. Presymptomatic Identification of Cancers in Pregnant Women During Noninvasive Prenatal Testing.
Amant F; Verheecke M; Wlodarska I; Dehaspe L; Brady P; Brison N; Van Den Bogaert K; Dierickx D; Vandecaveye V; Tousseyn T; Moerman P; Vanderstichele A; Vergote I; Neven P; Berteloot P; Putseys K; Danneels L; Vandenberghe P; Legius E; Vermeesch JR
JAMA Oncol; 2015 Sep; 1(6):814-9. PubMed ID: 26355862
[TBL] [Abstract][Full Text] [Related]
10. Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.
Nakabayashi M; Kawashima A; Yasuhara R; Hayakawa Y; Miyamoto S; Iizuka C; Sekizawa A
Sci Rep; 2018 Jul; 8(1):11205. PubMed ID: 30046040
[TBL] [Abstract][Full Text] [Related]
11. Improving the accuracy of noninvasive prenatal testing through size-selection between fetal and maternal cfDNA.
Kwon HJ; Yun S; Joo J; Park D; Do WJ; Lee S; Lee MS
Prenat Diagn; 2023 Dec; 43(13):1581-1592. PubMed ID: 37975672
[TBL] [Abstract][Full Text] [Related]
12. A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.
Noh JJ; Ryu HM; Oh SY; Choi SJ; Roh CR; Kim JH
Taiwan J Obstet Gynecol; 2019 Jul; 58(4):545-551. PubMed ID: 31307749
[TBL] [Abstract][Full Text] [Related]
13. Copy number variation profile in noninvasive prenatal testing (NIPT) can identify co-existing maternal malignancies: Case reports and a literature review.
Ji X; Chen F; Zhou Y; Li J; Yuan Y; Mo Y; Liu Q; Tseng JY; Shih-Chieh Lin D; Shen SH; Liu Y; Ye W; Cheung YN; Yuen KY; Lin S; Fu M; Zhang H; Liu N; Wang J; Yang H; Wang Y; Li S; Fan S; Jin X; Mao M; Sung PL
Taiwan J Obstet Gynecol; 2018 Dec; 57(6):871-877. PubMed ID: 30545544
[TBL] [Abstract][Full Text] [Related]
14. Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests.
Ji X; Li J; Huang Y; Sung PL; Yuan Y; Liu Q; Chen Y; Ju J; Zhou Y; Huang S; Chen F; Han Y; Yuan W; Fan C; Zhao Q; Wu H; Feng S; Liu W; Li Z; Chen J; Chen M; Yao H; Zeng L; Ma T; Fan S; Zhang J; Yuen KY; Cheng SH; Chik IWS; Liu NT; Zhu J; Lin S; Cao J; Tong S; Shan Z; Li W; Hekmat MR; Garshasbi M; Suela J; Torres Y; Cigudosa JC; Ruiz FJP; Rodríguez L; García M; Bernik J; Traven E; Reš U; Tul N; Tseng CF; Zhao D; Sun L; Pan Q; Shen L; Dai M; Wang Y; Wang J; Yang H; Yin Y; Duan T; Zhu B; Choolani M; Jin X; Chen Y; Mao M
Genet Med; 2019 Oct; 21(10):2293-2302. PubMed ID: 30976098
[TBL] [Abstract][Full Text] [Related]
15. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive Detection of Bladder Cancer by Shallow-Depth Genome-Wide Bisulfite Sequencing of Urinary Cell-Free DNA for Methylation and Copy Number Profiling.
Cheng THT; Jiang P; Teoh JYC; Heung MMS; Tam JCW; Sun X; Lee WS; Ni M; Chan RCK; Ng CF; Chan KCA; Chiu RWK; Lo YMD
Clin Chem; 2019 Jul; 65(7):927-936. PubMed ID: 30988170
[TBL] [Abstract][Full Text] [Related]
17. Genome-Wide Noninvasive Prenatal Diagnosis of De Novo Mutations.
Peretz-Machluf R; Rabinowitz T; Shomron N
Methods Mol Biol; 2021; 2243():249-269. PubMed ID: 33606261
[TBL] [Abstract][Full Text] [Related]
18. Predicting fetoplacental mosaicism during cfDNA-based NIPT.
Neofytou M
Curr Opin Obstet Gynecol; 2020 Apr; 32(2):152-158. PubMed ID: 31977337
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal HER2 amplification tracked in circulating tumor DNA for therapeutic effect monitoring and prognostic evaluation in patients with breast cancer.
Guan X; Liu B; Niu Y; Dong X; Zhu X; Li C; Li L; Yi Z; Sun X; Chen H; Lu S; Ma F
Breast; 2020 Feb; 49():261-266. PubMed ID: 31927339
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing.
Yu D; Zhang K; Han M; Pan W; Chen Y; Wang Y; Jiao H; Duan L; Zhu Q; Song X; Hong Y; Chen C; Wang J; Hui F; Huang L; Chen C; Du Y
Mol Genet Genomic Med; 2019 Jun; 7(6):e674. PubMed ID: 31004415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
